DSS DSS, INC.

NYSE dssworld.com


$ 1.35 $ 0.07 (4.68 %)    

Tuesday, 21-Oct-2025 19:36:19 EDT
QQQ $ 610.20 $ -0.16 (-0.03 %)
DIA $ 469.29 $ 2.20 (0.47 %)
SPY $ 670.99 $ -0.01 (0 %)
TLT $ 92.01 $ 0.45 (0.49 %)
GLD $ 377.70 $ -25.91 (-6.43 %)
$ 1.455
$ 1.39
$ 1.26 x 3,400
$ 1.45 x 99
$ 1.33 - $ 1.50
$ 0.72 - $ 1.90
600,872
na
13.23M
$ 0.55
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-27-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-31-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 09-14-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-18-2021 09-30-2021 10-Q
17 08-23-2021 06-30-2021 10-Q
18 05-14-2021 03-31-2021 10-Q
19 03-31-2021 12-31-2020 10-K
20 10-23-2020 09-30-2020 10-Q
21 08-14-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 03-31-2020 12-31-2019 10-K
24 11-13-2019 09-30-2019 10-Q
25 08-13-2019 06-30-2019 10-Q
26 05-14-2019 03-31-2019 10-Q
27 03-15-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-14-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 03-06-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 03-28-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-15-2016 06-30-2016 10-Q
38 05-16-2016 03-31-2016 10-Q
39 03-30-2016 12-31-2015 10-K
40 11-13-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 dss-incs-sweet-sense-has-received-a-decision-to-grant-european-patent-number-ep3618873-titled-low-glycemic-sugar-composition-to-control-blood-glucose-levels-and-treat-diabetes-and-related-conditions

https://register.epo.org/application?number=EP18855104

Core News & Articles

On July 21, 2025, Impact BioMedical Inc. (the "Company" or "Borrower") entered into a Debt Conversion Agreement...

 dss-impact-biomedical-enters-into-definitive-merger-agreement-with-dr-ashleys

DSS, Inc. (NYSE:DSS) ("DSS" or the "Company"), a multinational company operating across diverse industries incl...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION